Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
6.14
-0.85 (-12.16%)
At close: Dec 19, 2025, 4:00 PM EST
6.05
-0.09 (-1.47%)
After-hours: Dec 19, 2025, 7:45 PM EST
Intelligent Bio Solutions Market Cap
Intelligent Bio Solutions has a market cap or net worth of $5.8 million as of December 19, 2025. Its market cap has decreased by -20.30% in one year.
Market Cap
5.80M
Enterprise Value
6.10M
1-Year Change
-20.30%
Ranking
Category
Stock Price
$6.14
Market Cap Chart
Since December 23, 2020, Intelligent Bio Solutions's market cap has decreased from $108.04M to $5.80M, a decrease of -94.63%. That is a compound annual growth rate of -44.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 5.80M | -5.50% |
| Dec 31, 2024 | 6.14M | 108.12% |
| Dec 29, 2023 | 2.95M | -19.57% |
| Dec 30, 2022 | 3.67M | -82.82% |
| Dec 31, 2021 | 21.36M | -74.44% |
| Dec 31, 2020 | 83.54M | -22.67% |
| Dec 23, 2020 | 108.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 946.31B |
| Johnson & Johnson | 501.88B |
| AbbVie | 393.81B |
| UnitedHealth Group | 297.24B |
| AstraZeneca | 281.41B |
| Novartis AG | 260.53B |
| Merck & Co. | 249.91B |
| Abbott Laboratories | 217.56B |